Description
Recombinant monoclonal antibody to CD8. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma YTC 182.20.
Target
CD8
Target Alias Names
Leu2, CD8, CD8A, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2, CD8a, p32, YTC182.20
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression